SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.

Bibliographic Details
Title: SARS-CoV-2 omicron BA.5 and XBB variants have increased neurotropic potential over BA.1 in K18-hACE2 mice and human brain organoids.
Authors: Stewart, Romal, Kexin Yan, Ellis, Sevannah A., Bishop, Cameron R., Dumenil, Troy, Bing Tang, Nguyen, Wilson, Larcher, Thibaut, Parry, Rhys, De Jun Sng, Julian, Khromykh, Alexander A., Sullivan, Robert K. P., Lor, Mary, Meunier, Frédéric A., Rawle, Daniel J., Suhrbier, Andreas
Source: Frontiers in Microbiology; 2023, p1-18, 18p
Subject Terms: SARS-CoV-2 Omicron variant, SARS-CoV-2, ORGANOIDS, MICE, PROGENITOR cells
Abstract: The reduced pathogenicity of the omicron BA.1 sub-lineage compared to earlier variants is well described, although whether such attenuation is retained for later variants like BA.5 and XBB remains controversial. We show that BA.5 and XBB isolates were significantly more pathogenic in K18-hACE2 mice than a BA.1 isolate, showing increased neurotropic potential, resulting in fulminant brain infection and mortality, similar to that seen for original ancestral isolates. BA.5 also infected human cortical brain organoids to a greater extent than the BA.1 and original ancestral isolates. In the brains of mice, neurons were the main target of infection, and in human organoids neuronal progenitor cells and immature neurons were infected. The results herein suggest that evolving omicron variants may have increasing neurotropic potential. [ABSTRACT FROM AUTHOR]
Copyright of Frontiers in Microbiology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:1664302X
DOI:10.3389/fmicb.2023.1320856
Published in:Frontiers in Microbiology
Language:English